Xylo Technologies Ltd.
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Great Britain, Israel, Canada, Asia, and internationally. It operates through Corporate, Online Advertising & Internet Traffic Routing, Online Event Management, and Real-estate and Electronics segments. The company offers Medigus Ultrasonic Surgical Endostapler, an endosc… Read more
Xylo Technologies Ltd. (XYLO) - Total Assets
Latest total assets as of December 2024: $37.55 Million USD
Based on the latest financial reports, Xylo Technologies Ltd. (XYLO) holds total assets worth $37.55 Million USD as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Xylo Technologies Ltd. - Total Assets Trend (2016–2024)
This chart illustrates how Xylo Technologies Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Xylo Technologies Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Xylo Technologies Ltd.'s total assets of $37.55 Million consist of 55.9% current assets and 44.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 23.3% |
| Accounts Receivable | $5.43 Million | 14.5% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $9.70 Million | 25.8% |
| Goodwill | $5.07 Million | 13.5% |
Asset Composition Trend (2016–2024)
This chart illustrates how Xylo Technologies Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Xylo Technologies Ltd.'s current assets represent 55.9% of total assets in 2024, a decrease from 75.9% in 2016.
- Cash Position: Cash and equivalents constituted 23.3% of total assets in 2024, down from 63.5% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 38.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 25.8% of total assets.
Xylo Technologies Ltd. Competitors by Total Assets
Key competitors of Xylo Technologies Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Xylo Technologies Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Xylo Technologies Ltd. generates 0.80x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Xylo Technologies Ltd. is currently not profitable relative to its asset base.
Xylo Technologies Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.14 | 1.08 | 2.46 |
| Quick Ratio | 1.14 | 1.00 | 2.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.56 Million | $ 2.40 Million | $ 4.91 Million |
Xylo Technologies Ltd. - Advanced Valuation Insights
This section examines the relationship between Xylo Technologies Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.36 |
| Latest Market Cap to Assets Ratio | 0.18 |
| Asset Growth Rate (YoY) | -41.2% |
| Total Assets | $37.55 Million |
| Market Capitalization | $6.64 Million USD |
Valuation Analysis
Below Book Valuation: The market values Xylo Technologies Ltd.'s assets below their book value (0.18 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Xylo Technologies Ltd.'s assets decreased by 41.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Xylo Technologies Ltd. (2016–2024)
The table below shows the annual total assets of Xylo Technologies Ltd. from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $37.55 Million | -41.23% |
| 2023-12-31 | $63.90 Million | -34.57% |
| 2022-12-31 | $97.65 Million | +63.49% |
| 2021-12-31 | $59.73 Million | +84.72% |
| 2020-12-31 | $32.34 Million | +142.50% |
| 2019-12-31 | $13.33 Million | +18.64% |
| 2018-12-31 | $11.24 Million | +55.88% |
| 2017-12-31 | $7.21 Million | +52.77% |
| 2016-12-31 | $4.72 Million | -- |